Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Rectal Neoplasms × HMPL-013 × Clear all

Phase

Phase 2 2 Phase 2/3 1 Phase 1 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 1 Colorectal Neoplasms 1

Interventions

Oxaliplatin 4 Fluorouracil 4 Surgical Procedures, Operative 3 Radiotherapy 3 Leucovorin 3 Chemoradiotherapy 3 Neoadjuvant Therapy 2 Irinotecan 2 Folfox protocol 2 Drug Therapy 2 Capecitabine 2 Bevacizumab 2 sulindac sulfone 1 XELOX 1 Water 1 Surveys and Questionnaires 1 Preoperative Exercise 1 Photochemotherapy 1 N-dihydrogalactochitosan 1 Microwaves 1 Mental Status and Dementia Tests 1 Magnetic Resonance Spectroscopy 1 Leucine-tRNA Ligase 1 Injections 1 Indocyanine Green 1 In Situ Hybridization, Fluorescence 1 Immunohistochemistry 1 HMPL-013 1 Gene Expression Profiling 1 Cytogenetic Analysis 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06443671 2024-06-05

PKUCH-R09

Peking University Cancer Hospital & Institute

Phase 2/3 Not yet recruiting

Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡